News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Ventolin to remain available after 1 July

3 May 2005

Ventolin (Metered Dose Inhaler) to remain available after 1st July as a Private Purchase Medicine

Auckland, 2nd May 2005 – GlaxoSmithKline (GSK) will continue to make Ventolin™ (salbutamol) Metered Dose Inhaler (MDI) available to New Zealanders on prescription after July 1st as a Private Purchase Medicine (PPM) in order to ensure that New Zealanders continue to have access to an alternative to the funded options. This follows PHARMAC’s decision to award the sole supply tender for salbutamol to an alternative supplier from July 1st.

GSK will continue to make Ventolin MDI’s available at the price currently listed on the pharmaceutical schedule, although as a PPM the actual amount a patient could expect to pay will be determined by individual pharmacies and will vary.

“Given the level of inquiries that we have received from both patients and healthcare professionals, we expect that many people may want to continue to use Ventolin™ even after the subsidy ends on July 1st. We will obviously continue to review the level of demand on an ongoing basis.“ says Lisa Bright, Vice President and Managing Director, GSK Pharmaceuticals New Zealand.

GSK understands from an earlier PHARMAC press release that, “PHARMAC is considering deferring implementation of sole supply”. GSK understands that this does not necessarily mean that Ventolin will continue to be subsidised after the 1st of July. “We look forward to hearing the outcome of the PHARMAC review and hope that Ventolin can remain fully subsidised for New Zealanders as it has been for the last 35 years” said Ms Bright.

Currently, 90% of people with asthma in New Zealand rely on Ventolin to provide short acting relief of their asthma symptoms.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION